SEARLE HEALTHNETCARDIOVASCULARSEARLE HEALTHNET

the Searle commitment | Searle news bytes | related links

THE SEARLE COMMITMENT



COUPLE EXERCISING

TAKING YOUR HEALTH TO HEART

Cardiovascular disease is the leading killer worldwide. Although the medical community, including the pharmaceutical industry, has made great strides in developing treatments for a broad range of cardiovascular disorders, we still have a long way to go. To this day, no adequate treatment exists for acute stroke, which kills millions and leaves many more paralyzed each year. Likewise, we're still in search of a long-term therapy for congestive heart failure (CHF), which takes the lives of 50 percent of patients within 5 years of diagnosis.

But good news abounds. Management of high blood pressure, a key risk factor for stroke and CHF, is now easier given the extensive number of available medications used to create individualized therapy for each patient. For some conditions, such as coronary artery disease (CAD), surgery can be replaced by drug therapy. When operations are still required, new techniques enable higher survival rates and faster recuperation so that patients can return to normal lifestyles within a few weeks. Research into risk factors has spawned massive educational efforts that have successfully encouraged people to smoke less, reduce fat in their diets, and exercise more -- key components of heart-healthy lifestyles.

Searle is well-positioned at the forefront of cardiovascular medicine. We've made important contributions to the treatment of hypertension, CHF, CAD and arrhythmia. We're also well into the development of new medications for stroke and other conditions, and continue to improve our existing product lines in innovative ways. For example, we are pioneers in "chronotherapy" — offering a new formulation that enables people with heart disease to take medication that reaches maximum concentration at the time of day when blood pressure and heart rate are typically at their fastest rate of increase.

 

SEARLE NEWS BYTES
The full texts of these press releases are available online by clicking the headline.





 
For more info on these stories, contact Kristin Fayer (krfaye@searle.monsanto.com) at (847) 470-6728 or Jack Domeischel (jrdome@searle.monsanto.com) at (847) 470-6720.

For press releases older than six months, search Searle's press archive.

RELATED LINKS


WEB SITES:


The sites listed below are not sponsored by Searle and their listing here does not reflect Searle participation or endorsement. The listing is not all-inclusive but is provided as a guide to some of the sites that have related information.

 
USENET DISCUSSION GROUPS:

 
(Note: Information offered by discussion group participants may not be medically accurate and does not necessarily reflect the beliefs or knowledge of Searle or its employees. Please discuss any medical information gleaned from Internet discussion groups with your physician.)

If you know of a link that should be on this list, please contact webmaster@www.SearlehealthNet.com.

 

WHERE NEXT?



Follow the guided tour to the women's health feature or explore these links:

ARTHRITIS CARDIOVASCULAR WOMAN'S HEALTH




SEARLE HEALTHNETINTRODUCTIONSEARLEHEALTHCAREPIPELINESEARLE HEALTHNET

©1996, Searle. Send questions or comments to info@SearlehealthNet.com or bug reports to webmaster@SearlehealthNet.com.